image
Healthcare - Biotechnology - NASDAQ - US
$ 42.01
-5.13 %
$ 2.58 B
Market Cap
9.93
P/E
INCOME STATEMENT
434 M REVENUE
624.05%
253 M OPERATING INCOME
369.98%
275 M NET INCOME
448.54%
EFFICIENCY
Earnings Waterfall Protagonist Therapeutics, Inc.
image
Revenue 434 M
Cost Of Revenue 2.96 M
Gross Profit 431 M
Operating Expenses 182 M
Operating Income 253 M
Other Expenses -22.3 M
Net Income 275 M
450m450m400m400m350m350m300m300m250m250m200m200m150m150m100m100m50m50m00434m(3m)431m(182m)253m22m275mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
REVENUE
Revenue 434.4 60.0 26.6 27.4 28.6 0.2 30.9 20.1 0 0 0
GROSS PROFIT
Cost Of Revenue 3.0 0 1.0 2.8 0 0 0 0 0.3 0.2 0
Gross Profit 431.5 60.0 25.5 24.6 28.6 0.2 30.9 20.1 (0.3) (0.2) 0
OPERATING INCOME
Operating Expenses 181.6 153.7 158.0 153.2 93.1 80.8 73.2 58.0 32.7 14.8 9.3
Selling, General and Administrative Expenses 43.5 33.5 31.7 27.2 18.6 15.7 13.7 11.8 7.0 3.0 1.9
Research and Development Expenses 138.1 120.2 126.2 126.0 74.5 65.0 59.5 46.2 25.7 11.8 7.5
Operating Income 252.8 (93.7) (131.4) (125.8) (64.5) (80.5) (42.3) (37.9) (32.7) (14.8) (9.3)
PRE-TAX INCOME
Interest Income Expense 0 0 0 0 0.6 0.2 0 0 0 0 0
Total Other Income 26.6 14.7 4.0 0.3 (0.3) 2.6 2.5 0.9 (4.5) 64 K (1.8)
Pre-Tax Income 279.4 (79.0) (127.4) (125.6) (64.8) (77.9) (39.7) (37.0) (37.2) (14.9) (11.1)
NET INCOME
Tax Provision 4.2 0 (4.0) (2.9) 1.3 (0.7) (0.8) (0.4) 4.2 64 K 1.8
Net Income 275.2 (79.0) (123.4) (122.6) (66.2) (77.2) (38.9) (37.0) (37.2) (14.9) (11.1)
EPS 4.47 1.39 2.52 2.65 1.92 2.98 1.74 2.09 5.72 2.52 1.88